P53350 (PLK1_HUMAN) Homo sapiens (Human)
Serine/threonine-protein kinase PLK1 UniProtKBInterProSTRINGInteractive Modelling
603 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
73 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN |
Heteromer | 100 | ||||
| Crystal structure of human PLK1 Polo-Box Domain in complex with Mis18BP1 |
Heteromer Q6P0N0; | 100 | ||||
| Crystal structure of human Plk1-PBD in complex with WSSSLATPPTLSSpTVLI phosphopeptide from BRCA2 |
Heteromer P51587; | 100 | 1×GOL; | |||
| Polo-like kinase I Polo-box domain in complex with FMPPPMSpSM phosphopeptide from TCERG1 |
Heteromer O14776; | 100.0 | 1×1PE; 1×PEG; 1×PG0; | |||
| phospho-Pon binding-induced Plk1 dimerization |
Heteromer O96561; | 100.0 | 1×GOL; | |||
| Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centros… |
Heteromer P30307; | 100 | 1×FMT; | |||
| Plk1 polo-box domain bound to HPV18 L2 residues 209-215 with pThr213 |
Heteromer P06793; | 100.0 | ||||
| Plk1 polo-box domain bound to HPV4 L2 residues 251-257 with pThr255 |
Heteromer Q07862; | 100.0 | ||||
| Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centros… |
Heteromer P30307; | 100.0 | ||||
| Crystal structure of human PLK1 Polo-Box Domain in complex with Mis18 |
Heteromer Q9NYP9; | 100.0 | ||||
| PLK1 in complex with BI6727 | homo-2-mer | 99.66 | 2×IBI; 8×EDO; 4×ACT; 2×PEG; 2×ZN; 2×GOL; | |||
| Crystal structure of Polo-like kinase 1 in complex with NMS-P937 | homo-2-mer | 100 | 2×937; 2×ZN; 2×TLA; | |||
| CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO- PYRIMIDIN-4-YL)-1H-PYRROLE IN… | homo-2-mer | 100 | 2×ZN; 2×TLA; 2×939; | |||
| CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRA… | homo-2-mer | 100 | 2×ZN; 2×TLA; 2×664; | |||
| Crystal structure of Polo-like kinase 1 in complex with a pyrazoloquinazoline inhibitor | homo-2-mer | 100 | 2×071; 2×ZN; 2×TLA; | |||
| Structure of PLK1 in complex with BI2536 | monomer | 99.66 | 1×ZN; 1×R78; 2×TLA; 2×SRT; 1×TAR; | |||
| Structure of the Catalytic Domain of Human Polo-like Kinase 1 | monomer | 99.66 | 1×ZN; 2×ACT; 1×626; | |||
| The Crystal Structure of PLK1 from Biortus. | monomer | 99.66 | 1×ANP; 1×ZN; 2×ACT; 2×PEG; 3×EDO; | |||
| Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitor. | monomer | 99.66 | 1×79D; 1×ZN; | |||
| Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitor | monomer | 99.66 | 1×ZN; 1×79C; | |||
| Crystal structure of PLK1 in complex with a pyrimidodiazepinone inhibitor | monomer | 99.66 | 1×1J3; 1×ZN; 1×ACT; | |||
| Crystal structure of PLK1 in complex with TAK-960 | monomer | 99.66 | 1×ZN; 1×ACT; 1×1J4; | |||
| Structure of human PLK1 in complex with 2-Allyl-1-[6-(1-hydroxy-1-methyl-ethyl)-pyridin-2-yl]-6-[4-… | monomer | 99.66 | 1×ACT; 1×8X7; 1×ZN; | |||
| Structure of the Catalytic Domain of Human Polo-like Kinase 1 | monomer | 99.66 | 1×ZN; 2×ACT; 2×MG; 1×ANP; | |||
| Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitor | monomer | 99.65 | 1×ZN; 1×3TA; | |||
| Structure of PLK1 in complex with peptide | monomer | 100 | 3×PO4; | |||
| Polo-like kinase 1 Polo box domain in complex with Ac-LHSpTA-NH2 peptide | monomer | 100 | ||||
| Crystal structure of Plk1 Polo-box domain in complex with PL-74 | monomer | 100.0 | 1×SO4; 1×GOL; | |||
| Crystal structure of Plk1 Polo-box domain in complex with PL-2 | monomer | 100.0 | 10×EDO; | |||
| PLK-1 polo-box domain in complex with Bioactive Imidazolium-containing phosphopeptide macrocycle 4C | monomer | 100 | ||||
| The Crystal Structure of polo-box domain of PLK1 from Biortus. | monomer | 100.0 | 1×EDO; | |||
| PLK-1 polo-box domain in complex with Bioactive Imidazolium-containing phosphopeptide macrocycle 3C | monomer | 100.0 | ||||
| Structure of human Plk1 PBD in complex with Allopole-A | monomer | 100.0 | 1×GOL; 1×VIH; | |||
| Unliganded form of Polo-like kinase I Polo-box domain | monomer | 100.0 | 2×SO4; 3×GOL; | |||
| Structure of human Plk1-PBD in complex with PLHSpT | monomer | 100 | 2×GOL; 1×EDO; | |||
| The structure of the polo-box domain (PBD) of Plk1 in complex with Z228588490 | monomer | 100.0 | 1×Z24; | |||
| human Plk1-PBD with a glycerol bound at the phophopeptide binding site | monomer | 100.0 | ||||
| The polo-box domain of Plk1 in complex with a phospho-peptide | monomer | 100 | ||||
| Polo-like kinase I Polo-box domain in complex with FDPPLHSpTA phosphopeptide from PBIP1 | monomer | 100 | 2×GOL; | |||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with JES107 | monomer | 100.0 | 1×8VB; | |||
| Human Plk1-PBD in complex with Thymoquinone at the phophopeptide binding site | monomer | 100.0 | ||||
| Plk-1 polo-box domain in complex with histidine N(tau)-cyclized Macrocycle 5b. | monomer | 100.0 | 1×AML; | |||
| Polo-like kinase I Polo-box domain in complex with DPPLHSpTA phosphopeptide from PBIP1 | monomer | 100.0 | 1×GOL; 1×PO4; | |||
| Structure of human Plk1-PBD with glycerol and sulfate in the phophopeptide binding site | monomer | 100 | 3×SO4; 4×GOL; 1×EDO; | |||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with LDPPLHSpTA … | monomer | 100 | 2×PG0; 1×GOL; | |||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) | monomer | 100.0 | ||||
| Polo-like kinase I Polo-box domain in complex with PLHSpTA phosphopeptide from PBIP1 | monomer | 100.0 | 1×GOL; | |||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with LHSpTA pept… | monomer | 100 | ||||
| Structure of a human Plk1 Polo-box domain/phosphopeptide complex | monomer | 100 | ||||
| Molecular and structural basis of Plk1 substrate recognition: Implications in centrosomal localizat… | monomer | 100.0 | ||||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with Alpha-Bromo… | monomer | 100.0 | 1×8Z5; | |||
| Crystal structure of polo-like kinase(PLK1)PBD in complex with DD-1 | monomer | 100 | ||||
| Crystal structure of Plk1 Polo-box domain in complex with PL-42 | monomer | 100.0 | ||||
| The structure of the polo-box domain (PBD) of Plk1 in complex with Alpha-Bromo-3-Iodotoluene. | monomer | 100.0 | 1×8Z5; | |||
| Polo-like kinase I Polo-box domain in complex with MQSpSPL phosphopeptide | monomer | 100.0 | 2×GOL; | |||
| Crystal structure of Plk1 Polo-box domain in complex with PL-49 | monomer | 100 | 2×CXS; 1×PO4; | |||
| Polo-like kinase I Polo-box domain in complex with MQSpTPL phosphopeptide | monomer | 100 | 2×SO4; 1×GOL; | |||
| Peptide-Based Inhibitors of Plk1 Polo-box Domain | monomer | 100.0 | ||||
| Polo-like kinase 1 Polo box domain in complex with a C6H5(CH2)8-derivatized peptide inhibitor | monomer | 100.0 | ||||
| Crystal structure of Plk1 Polo-box domain in complex with PL-55 | monomer | 100.0 | 1×ADM; | |||
| PLK-1 polo-box domain in complex with a high affinity macrocycle synthesized using a novel glutamic… | monomer | 100.0 | 1×ZOY; | |||
| Crystal structure of polo-like kinase(PLK1)PBD in complex with phospho peptide | monomer | 100.0 | ||||
| Human Plk1-PBD in complex with Poloxime ((E)-4-(hydroxyimino)-2-isopropyl-5-methylcyclohexa-2,5-die… | monomer | 100.0 | ||||
| The structure of the polo box domain of human Plk1 | monomer | 100.0 | ||||
| A New Class of Peptidomimetics Targeting the Polo-box Domain of Polo-like kinase 1 | monomer | 100.0 | ||||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with 3-(1-benzot… | monomer | 100 | 1×GOL; | |||
| Oxime-based Post Solid-phase Peptide Diversification: Identification of High Affinity Polo-like Kin… | monomer | 100.0 | 2×CL; | |||
| The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with hydrocinnam… | monomer | 100.0 | ||||
| Polo-like kinase 1 Polo box domain in complex with PPHSpT peptide | monomer | 100.0 | ||||
| PLK-1 polo-box domain in complex with Bioactive Imidazolium-containing phosphopeptide macrocycle 3B | monomer | 100 | ||||
| A New Class of Peptidomimetics Targeting the Polo-box Domain of Polo-like kinase 1 | monomer | 100 | ||||
| Crystal Structure of Polo Box Domain in Complex with Cyclic Peptide Inhibitor | monomer | 100.0 | ||||
| A New Class of Peptidomimetics Targeting the Polo-box Domain of Polo-like kinase 1 | monomer | 100.0 | 2×SO4; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1q4k.2.A | monomer | 0.87 | 1×MET; | 100.00 | ||
| 5ta6.1.A | monomer | 0.84 | 1×79D; | 99.68 | ||